Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 451 - 500 out of 10,644

Document Document Title
WO/2009/043784A1
Compounds of the formula (I) wherein Ar1, Ar2, R1 and R2 are as defined herein. Also provided are pharmaceutical compositions, methods of using, and methods of preparing the subject compounds.  
WO/2009/040590A1
For the manufacturing of a complex product with advanced assimilation efficacy, including methyl-methionine sulphonium, carboxyl-uracil, paraaminobenzoic acid, dimethyl-sulfoxide and poliethoxy castor oil, and its utilization.  
WO/2009/038463A1
The invention relates to new, highly efficient UV - absorbing compounds, a process for their manufacturing and to uses of these UV - absorbing compounds. The UV - absorbing compounds are in particular UV - A - absorbing compounds accordi...  
WO/2009/030752A1
The present invention relates to compounds of formula (I) : as well as to cosmetic and pharmaceutical compositions containing such a compound.  
WO/2009/027004A1
The invention relates to a novel thermodynamically stable crystal modification of 2-({2-chloro-4-(methylsulfonyl)-3-[(2,2,2-trifluoroethoxy)me thyl]phenyl}carbonyl)cyclohexane-1,3-dione. A thermodynamically stable crystal modification of...  
WO/2009/024863A3
Disclosed herein is a convenient, commercially viable and environmentally friendly process for the preparation of Armodafinil. The present invention also provides an improved, commercially viable and industrially advantageous process for...  
WO/2009/025791A2
The invention encompasses processes for obtaining pure armodafinil substantially free of disulfide impurities that is suitable for use on an industrial scale. In particular, a processes for purifying armodafinil from bis(diphenylmethyl)d...  
WO/2009/024863A2
Disclosed herein is a convenient, commercially viable and environmentally friendly process for the preparation of Armodafinil. The present invention also provides an improved, commercially viable and industrially advantageous process for...  
WO/2009/025791A3
The invention encompasses processes for obtaining pure armodafinil substantially free of disulfide impurities that is suitable for use on an industrial scale. In particular, a processes for purifying armodafinil from bis(diphenylmethyl)d...  
WO/2009/022681A1
Disclosed is a positive resist composition which is good in pattern shape, line-edge roughness, pattern collapse, sensitivity and resolution in conventional exposure (dry exposure), liquid immersion exposure and double exposure. Also dis...  
WO/2009/018824A1
A composition comprising specific beta-blockers such as bisoprolol and nebivolol for the treatment of insomnia and/or another sleep disorder. The composition should be given in such an amount that it causes a less than 40 % decrease in t...  
WO/2009/014268A1
There is provided a fluorine-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein G represents an oxygen atom or a sulfur atom; R2 represents a C1-C4 chain hyd...  
WO/2009/010156A2
The invention relates to compounds of formula (I) or the salts thereof, wherein Q is a (hetero)aromatic radical having up to 6 ring atoms, the ring of the heteroaromatic radical comprising 1, 2, 3 or 4 nitrogen atoms or 1 sulphur atom or...  
WO/2009/010156A3
The invention relates to compounds of formula (I) or the salts thereof, wherein Q is a (hetero)aromatic radical having up to 6 ring atoms, the ring of the heteroaromatic radical comprising 1, 2, 3 or 4 nitrogen atoms or 1 sulphur atom or...  
WO/2009/009041A3
The invention relates to compounds and methods for modulating one or more components of a kinase cascade.  
WO/2009/008905A1
Compounds having the formula : (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of phenoxy-acetic acids and analogs capable of inhibiting the lethal effects of infection by anthrax b...  
WO/2009/008905A4
Compounds having the formula : (I) wherein the symbols have the meaning described in the specification are hydroxamic acid derivatives of phenoxy-acetic acids and analogs capable of inhibiting the lethal effects of infection by anthrax b...  
WO/2009/009041A2
The invention relates to compounds and methods for modulating one or more components of a kinase cascade.  
WO/2009/005110A3
There is provided a halogen-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein, m represents 0, 1 or 2, n represents 0, 1 or 2, A represents optionally subst...  
WO/2009/005110A2
There is provided a halogen-containing organosulfur compound having an excellent controlling effect on arthropod pests represented by the formula (I): wherein, m represents 0, 1 or 2, n represents 0, 1 or 2, A represents optionally subst...  
WO2008115999A8
This invention is directed to compounds of formula (I), wherein A, B, m, n, R1, R2 and R3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodr...  
WO/2008/157216A1
The present invention provides a process for the manufacture of an arylmethyl-sulfonylarene, R1CH2SO2R2, wherein R1 and R2 are each independently an optionally substituted phenyl or naphthyl group which process comprises reacting an aryl...  
WO/2008/153159A1
It is intended to provide a novel amine compound represented by the following general formula (I), a pharmaceutically acceptable acid addition salt thereof, a hydrate thereof or a solvate thereof, which has an excellent peripheral blood ...  
WO/2008/151211A1
The present invention relates to A compound of the formula Ia wherein in any of its stereoisomers forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as desc...  
WO/2008/148468A1
The present invention relates to di(hetero)arylcyclohexane derivatives of the formula (I), in which Ar1, Ar2, R1 and R2 have the meanings indicated in the claims. The compounds of the formula (I) are valuable pharmaceutical active compou...  
WO/2008/149141A3
The present invention relates to a process for the preparation of polymorphic forms of the R- and S-enantiomers of modafinil, R-(-)-2-benzhydrylsulfinylacetamide and S-(+)-2- benzhydrylsulfinylacetamide respectively.  
WO/2008/149141A2
The present invention relates to a process for the preparation of polymorphic forms of the R- and S-enantiomers of modafinil, R-(-)-2-benzhydrylsulfinylacetamide and S-(+)-2- benzhydrylsulfinylacetamide respectively.  
WO/2008/143338A1
There is provided an organic sulfur compound having an excellent controlling effect on harmful arthropods represented by the formula (I): wherein, R1 represents a C3-C10 alkenyl group optionally substituted with at least one halogen atom...  
WO/2008/143333A1
There is provided an organic sulfur compound having an excellent controlling effect on harmful arthropods which is represented by formula (I): wherein R1 represents a C3-C6 haloalkyl group having at least one fluorine atom and at least o...  
WO/2008/143332A1
There is provided an organic sulfur compound having an excellent controlling effect on harmful arthropods represented by the formula (I): wherein, R1 represents a C1-C5 haloalkyl group having at least one fluorine atom, R2 represents a C...  
WO/2008/133112A1
Disclosed is (1) a sulfone compound having a propargyl group. Also disclosed is (2) a nonaqueous electrolyte solution for lithium secondary batteries, which is obtained by dissolving an electrolyte in a nonaqueous solvent, which nonaqueo...  
WO/2008/123207A1
[PROBLEMS] To provide a compound useful as a therapeutic agent for chronic renal failure or diabetic neuropathy. [MEANS FOR SOLVING PROBLEMS] Disclosed is an ornithine derivative having an EP4 receptor antagonistic activity. In the compo...  
WO/2008/121877A3
The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administerin...  
WO/2008/119176A1
This invention describes an amidation process whereby amino acids of the Formulae IIA or IIB can be activated and treated with an amine in the presence of a base to yield amides of the Formula (I), without loss of optical purity.  
WO/2008/114275A2
The present invention provides novel anthranilic acid derivative useful as potential anticancer agent. More particularly, the present invention relates novel anthranilic acid derivative of general formula (8), R' = alkyl-2-methoxyphenyl ...  
WO/2008/114275A3
The present invention provides novel anthranilic acid derivative useful as potential anticancer agent. More particularly, the present invention relates novel anthranilic acid derivative of general formula (8), R' = alkyl-2-methoxyphenyl ...  
WO/2008/115999A1
This invention is directed to compounds of formula (I), wherein A, B, m, n, R1, R2 and R3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodr...  
WO/2008/110308A3
Cyclohexanedione compounds, and derivatives thereof, which are substituted in 5-position, are suitable for use as herbicides.  
WO/2008/111563A1
[PROBLEMS] To produce an optically active sulfoxide compound which is useful as an intermediate or a starting material for the synthesis of a physiologically active substance such as a pharmaceutical agent, at high optical purity. [MEANS...  
WO/2008/110308A2
Cyclohexanedione compounds, and derivatives thereof, which are substituted in 5-position, are suitable for use as herbicides.  
WO/2008/110621A1
The present invention relates to two crystalline forms of 2-[2-chloro-4-methylsulfonyl-3-(2,2,2-trifluoro-ethoxymethyl )benzoyl]cyclohexan-1,3-dione, which is also known under the common name tembotrione. The invention also relates to a ...  
WO/2008/108735A1
The present invention relates to 2-(substituted sulphur, sulphone or sulphoxide)-3-(substituted phenyl) propionic acid derivatives, 2-(substituted oxygen)-3-(substituted phenyl) propionic acid derivatives, benzoic acid derivatives, and d...  
WO/2008/107611A3
The invention concerns the use of at least one diol and/or at least one triol as an additive to dimethylsulfoxide (DMSO) in order to lower the crystallization point of same. The DMSO formulation is used in combination with the aforementi...  
WO/2008/109697A3
Compounds of Formula I, wherein Ar, L, m, R1, R2, R3, W, X, Y, Z are as defined in the claims, are described that are active on at least one of PPARα, PPARδ and PPARγ, which are useful for therapeutic and/or prophylactic methods invol...  
WO/2008/109697A2
Compounds of Formula I, wherein Ar, L, m, R1, R2, R3, W, X, Y, Z are as defined in the claims, are described that are active on at least one of PPARα, PPARδ and PPARγ, which are useful for therapeutic and/or prophylactic methods invol...  
WO/2008/093711A1
Disclosed is a solid-phase oxidation reaction system for an organic compound, which has such advantages that the system does not require any organic solvent which may adversely affect the global environment, has a high product yield, ena...  
WO/2008/093506A1
Disclosed is a recording material composition which comprises a crosslinked diphenylsulfone compound and a monohydroxydiphenylsulfone derivative and is excellent in color-developing property and image storage stability. Specifically disc...  
WO/2008/078811A1
It is intended to provide a novel herbicide which has a wide range of applications to arable and non-arable lands and the like, and various methods for application to soil treatment, stem and leaf treatment and the like, and exhibits an ...  
WO/2008/078674A1
Disclosed is a compound represented by the formula (1) or a pharmaceutically acceptable salt thereof, wherein a carbon atom having an asterisk has an R-configuration; R1 and R2 independently represent a hydrogen atom, a halogen atom, an ...  
WO/2008/076256A1
The present invention discloses prodrugs of chloramphenicol, thiamphenicol and their analogs, as well as pharmaceutically acceptable salts thereof, including nitrogen-containing esters of both alcohol groups. These prodrugs have the Form...  

Matches 451 - 500 out of 10,644